301096 百誠醫藥
按盤價 
38.800 -4.930 (-11.274%)
38.800 -4.930 (-11.274%) | 2026/09 - 九個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.323 | -3.567 | -2.004 | 10.528 | 8.089 |
| 總資產報酬率 ROA (%) | -2.216 | -2.441 | -1.427 | 8.243 | 6.633 |
| 投入資產回報率 ROIC (%) | -2.326 | -2.575 | -1.542 | 8.966 | 7.062 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.147 | 39.503 | 51.982 | 65.528 | 67.373 |
| 營業利潤率 (%) | -18.000 | -13.132 | -4.289 | 29.193 | 31.057 |
| 息稅前利潤/營業總收入 (%) | -15.591 | -10.783 | -3.972 | 26.977 | 24.546 |
| 淨利潤/營業總收入 (%) | -18.363 | -13.333 | -6.600 | 26.735 | 31.946 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 110.285 | 77.193 | 22.084 | 102.449 | 90.733 |
| 價值變動淨收益/利潤總額(%) | -11.734 | 12.944 | 15.506 | -0.036 | -2.081 |
| 營業外收支淨額/利潤總額(%) | 4.043 | 2.309 | 4.624 | -0.454 | 1.185 | 償債能力分析 |
| 流動比率 (X) | 1.825 | 1.687 | 2.009 | 1.900 | 5.538 |
| 速動比率 (X) | 1.609 | 1.495 | 1.778 | 1.790 | 5.311 |
| 資產負債率 (%) | 34.140 | 32.480 | 30.684 | 26.845 | 15.273 |
| 帶息債務/全部投入資本 (%) | 28.607 | 26.613 | 22.861 | 15.212 | 3.570 |
| 股東權益/帶息債務 (%) | 241.596 | 266.351 | 321.431 | 529.979 | 2,540.417 |
| 股東權益/負債合計 (%) | 192.866 | 207.878 | 225.906 | 272.510 | 554.820 |
| 利息保障倍數 (X) | -4.923 | -4.054 | -7.575 | -12.943 | -3.566 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 308.054 | 220.014 | 126.015 | 61.820 | 67.053 |
| 存貨周轉天數 (天) | 188.329 | 155.259 | 126.454 | 81.715 | 80.748 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 09/11/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
